Middle East & Africa Vaccines Market to 2032
Overview
The Middle East & Africa Vaccines Market is expected to reach a 1,828.27 USD Billion by 2032 and is projected to grow at a CAGR of 9.26% from 2025 to 2032.
Revenue, 2024 (USD Billion)
1,117.66
Forecast, 2032 (USD Billion)
1,828.27
CAGR, 2024 - 2032
9.26%
Report Coverage
Middle East & Africa
Middle East & Africa Vaccines Market 2018-2032 USD Billion
Middle East & Africa Vaccines Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 1,117.66 USD Billion
- Projected Market Size (2032): 1,828.27 USD Billion
- CAGR (2025-2032): 9.26%
Key Findings of Middle East & Africa Vaccines Market
- The Middle East & Africa Vaccines Market was valued at 1,117.66 USD Billion in 2024.
- The Middle East & Africa Vaccines Market is likely to grow at a CAGR of 9.26% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Injectable in Route of Administration Segment accounted for the largest share of the market with a revenue of 1,016.95 USD Billion
- The fastest growing segment Influenza in Diseases Segment grew Fastest with a CAGR of 11.10% during the forecast period from 2024 to 2032.
Middle East & Africa Vaccines Market Scope
Middle East & Africa Vaccines Market Segmentation & Scope
Route of Administration
- Nasal
- Oral
- Injectable
Diseases
- Yellow Fever
- Japanese Encephalitis
- Rabies
- Varicella
- Meningococcal
- Typhoid
- Influenza
- Hepatitis
- DPT
- Measles, Mumps & Rubella
- Pneumoccocal Disease
- Others
End User
- Others
- Clinics
- Specialty Centres
- Hospitals
- Community Hospitals
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
Age of Administration
- Adult Vaccines
- Pediatric Vaccines
Kind
- Required Vaccine
- Recommended Vaccines
- Routine Vaccine
Type
- DNA Vaccines (Zika Virus)
- Toxoid Vaccines
- Inactivated Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines
Composition
- Mono Vaccines
- Combination Vaccines
Middle East & Africa Vaccines Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 1,117.66 USD Billion |
| Market Value in 2032 | 1,828.27 USD Billion |
| CAGR (2025-2032) | 9.26% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Route of Administration,Diseases,End User,Distribution Channel,Age of Administration,Kind,Type,Composition |
Regional Insights:
-
Leading Market (2024-2032): Middle East & Africa, leading in terms of revenue 1,117.66 USD Billion in 2024
- Key Country: Saudi Arabia, leading in terms of revenue with value of 413.05 USD Billion in 2024.
Segments and Scope
-
Middle East & Africa Vaccines Market to 2032, By Route of Administration
- Injectable is the largest segment in Middle East & Africa Vaccines Market to 2032 with a revenue of 1,016.95 USD Billion in the year 2024.
- Injectable is the Fastest growing segment in Middle East & Africa Vaccines Market to 2032 with a Growth rate of 9.40 % in forecast period 2025-2032.
-
Middle East & Africa Vaccines Market to 2032, By Diseases
- Pneumoccocal Disease is the largest segment in Middle East & Africa Vaccines Market to 2032 with a revenue of 176.01 USD Billion in the year 2024.
- Influenza is the Fastest growing segment in Middle East & Africa Vaccines Market to 2032 with a Growth rate of 10.59 % in forecast period 2025-2032.
-
Middle East & Africa Vaccines Market to 2032, By End User
- Community Hospitals is the largest segment in Middle East & Africa Vaccines Market to 2032 with a revenue of 719.15 USD Billion in the year 2024.
- Specialty Centres is the Fastest growing segment in Middle East & Africa Vaccines Market to 2032 with a Growth rate of 8.99 % in forecast period 2025-2032.
-
Middle East & Africa Vaccines Market to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in Middle East & Africa Vaccines Market to 2032 with a revenue of 794.59 USD Billion in the year 2024.
- Retail Pharmacy is the Fastest growing segment in Middle East & Africa Vaccines Market to 2032 with a Growth rate of 8.73 % in forecast period 2025-2032.
-
Middle East & Africa Vaccines Market to 2032, By Age of Administration
- Pediatric Vaccines is the largest segment in Middle East & Africa Vaccines Market to 2032 with a revenue of 670.35 USD Billion in the year 2024.
- Adult Vaccines is the Fastest growing segment in Middle East & Africa Vaccines Market to 2032 with a Growth rate of 8.98 % in forecast period 2025-2032.
-
Middle East & Africa Vaccines Market to 2032, By Kind
- Routine Vaccine is the largest segment in Middle East & Africa Vaccines Market to 2032 with a revenue of 758.63 USD Billion in the year 2024.
- Recommended Vaccines is the Fastest growing segment in Middle East & Africa Vaccines Market to 2032 with a Growth rate of 8.79 % in forecast period 2025-2032.
-
Middle East & Africa Vaccines Market to 2032, By Type
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines is the largest segment in Middle East & Africa Vaccines Market to 2032 with a revenue of 436.15 USD Billion in the year 2024.
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines is the Fastest growing segment in Middle East & Africa Vaccines Market to 2032 with a Growth rate of 10.02 % in forecast period 2025-2032.
-
Middle East & Africa Vaccines Market to 2032, By Composition
- Combination Vaccines is the largest segment in Middle East & Africa Vaccines Market to 2032 with a revenue of 863.39 USD Billion in the year 2024.
- Combination Vaccines is the Fastest growing segment in Middle East & Africa Vaccines Market to 2032 with a Growth rate of 9.53 % in forecast period 2025-2032.
Middle East & Africa Vaccines Market Company Share Analysis
Middle East & Africa Vaccines Market Geographical Sales Distribution, 2018-2032 USD Billion
Middle East & Africa Vaccines Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Middle East & Africa Vaccines Market is segmented based on Segmentation Route of Administration,Diseases,End User,Distribution Channel,Age of Administration,Kind,Type,Composition.
Middle East & Africa Vaccines Market was valued at USD 1,117.66(Revenue in USD Billion) in 2020.
Middle East & Africa Vaccines Market is projected to grow at a CAGR of 9.26% during the forecast period of 2024 to 2032.
The Injectable segment is expected to dominate the Middle East & Africa Vaccines Market, holding a largest market share of 1,016.95 USD Billion in 2024
Middle East & Africa Vaccines Market Scope
Middle East & Africa Vaccines Market Segmentation & Scope
Route of Administration
- Nasal
- Oral
- Injectable
Diseases
- Yellow Fever
- Japanese Encephalitis
- Rabies
- Varicella
- Meningococcal
- Typhoid
- Influenza
- Hepatitis
- DPT
- Measles, Mumps & Rubella
- Pneumoccocal Disease
- Others
End User
- Others
- Clinics
- Specialty Centres
- Hospitals
- Community Hospitals
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
Age of Administration
- Adult Vaccines
- Pediatric Vaccines
Kind
- Required Vaccine
- Recommended Vaccines
- Routine Vaccine
Type
- DNA Vaccines (Zika Virus)
- Toxoid Vaccines
- Inactivated Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines
Composition
- Mono Vaccines
- Combination Vaccines
Frequently Asked Questions
The Middle East & Africa Vaccines Market is segmented based on Segmentation Route of Administration,Diseases,End User,Distribution Channel,Age of Administration,Kind,Type,Composition.
Middle East & Africa Vaccines Market was valued at USD 1,117.66(Revenue in USD Billion) in 2020.
Middle East & Africa Vaccines Market is projected to grow at a CAGR of 9.26% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Vaccines Market for final year is USD 1,828.27 (USD Billion).
Middle East & Africa Vaccines Market Company Profiling
Frequently Asked Questions
The Middle East & Africa Vaccines Market is segmented based on Segmentation Route of Administration,Diseases,End User,Distribution Channel,Age of Administration,Kind,Type,Composition.
Middle East & Africa Vaccines Market was valued at USD 1,117.66(Revenue in USD Billion) in 2020.
Middle East & Africa Vaccines Market is projected to grow at a CAGR of 9.26% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Vaccines Market for final year is USD 1,828.27 (USD Billion).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.